Goutam Chowdhury Selected Research

Goutam Chowdhury Research Topics

Disease

9	Neoplasms (Cancer) 04/2021 - 09/2003
8	Cholera 01/2021 - 08/2010
3	Diarrhea 01/2022 - 04/2013
3	Hypoxia (Hypoxemia) 01/2012 - 09/2003
2	Triple Negative Breast Neoplasms 04/2021 - 01/2021
2	Infections 12/2019 - 09/2013
2	Breast Neoplasms (Breast Cancer) 10/2019 - 09/2018
2	Multiple Myeloma 01/2017 - 01/2014
2	Leprosy (Hansen's Disease) 01/2017 - 01/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Hemolysis 01/2021
1	Carcinogenesis 01/2021
1	COVID-19 10/2020
1	Inflammation (Inflammations) 10/2020
1	Morning Sickness 01/2017
1	Enterobacteriaceae Infections 10/2016
1	Parkinson Disease (Parkinson's Disease) 02/2013
1	Colorectal Neoplasms (Colorectal Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 04/2021 - 09/2003
5	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 09/2003
4	Tirapazamine (SR 4233)IBA 01/2012 - 09/2003
3	VaccinesIBA 01/2022 - 08/2010
3	Cholera ToxinIBA 01/2021 - 08/2010
3	Oxygen (Dioxygen)IBA 01/2012 - 11/2004
2	SurvivinIBA 04/2021 - 09/2018
2	Hemolysin Proteins (Hemolysins)IBA 01/2021 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 09/2018 - 10/2016
2	glutarimideIBA 01/2017 - 01/2014
2	AntiemeticsIBA 01/2017 - 01/2014
2	Hypnotics and Sedatives (Sedatives)IBA 01/2017 - 01/2014
2	Thalidomide (Thalomid)FDA Link 01/2017 - 01/2014
2	Cholera Vaccines FDA Link 01/2014 - 08/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2012 - 10/2007
1	ProteomeIBA 01/2021
1	thermostable direct hemolysinIBA 01/2021
1	AshwagandhaIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	Sulfhydryl Compounds (Thiols)IBA 10/2020
1	Oxidants (Oxidizing Agents)IBA 10/2020
1	SolutionsIBA 08/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2019
1	Epidermal Growth Factor (EGF)IBA 10/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	sepantroniumIBA 09/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	Drug CombinationsIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 10/2016
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2016
1	Chemotactic FactorsIBA 09/2013
1	Opioid Analgesics (Opioids)IBA 02/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2013
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2013
1	myxinIBA 01/2012
1	Cyclic N-Oxides (Oxides, Cyclic N)IBA 01/2012
1	Anti-Infective Agents (Microbicides)IBA 08/2011
1	ABO Blood-Group SystemIBA 08/2010
1	Blood Group Antigens (Blood Groups)IBA 08/2010
1	Hydroxyl RadicalIBA 10/2007
1	Cytotoxins (Cytolysins)IBA 10/2007
1	3-amino-1,2,4-benzotriazineIBA 10/2007
1	3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxideIBA 11/2004
1	3-amino-2-quinoxalinecarbonitrileIBA 11/2004
1	EnzymesIBA 11/2004

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2019
1	Drug Therapy (Chemotherapy) 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Fluid Therapy (Oral Rehydration Therapy) 04/2013